Indivior Pharmaceuticals, Inc. INDV Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 80.2%-0.4pp | 80.6%-3.5pp | 84.1%+0.8pp | |
| Operating margin | 21.1%+17.9pp | 3.2%+17.1pp | -13.9%-5.4pp | |
| Net margin | 16.9%+16.3pp | 0.6%+12.1pp | -11.5%-6.9pp | |
| Efficiency | ||||
| Asset turnover | 1×+0.2× | 0.8×— | —— | |
| Liquidity | ||||
| Current ratio | 0.7×-0.2× | 0.9×-0.1× | 1×— | |
| Leverage | ||||
| Net debt / EBITDA | 0.6×-0.5× | 1×— | —— | |
| Per Share | ||||
| Book value per share | -$0.77+69.8% | -$2.53-88.7% | -$1.34-1,145% | |
| Valuation | ||||
| Market capitalization | $4.49B+189% | $1.55B-24.3% | $2.05B— | |
| Price / earnings | 21.5×-200× | 221.9×— | —— | |
| Price / sales | 3.6×+2.3× | 1.3×-0.6× | 1.9×— | |
| EV / EBITDA | 17.1×-12.7× | 29.8×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Indivior Pharmaceuticals, Inc. 's profit margins?
- Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.
- Where do Indivior Pharmaceuticals, Inc. 's ratios come from?
- Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
